Clinical Research Directory
Browse clinical research sites, groups, and studies.
Benefit of High-flow Nasal Cannula on Persistent Dyspnea in Ild
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
The main purpose of this study is to evaluate the effects of high-flow nasal therapy (HFNT) oxygen compared to long-term oxygen therapy (LTOT) on dyspnea and quality of life in intersititial lung disease patients with chronic respiratory failure and persistent breathlessness in whom LTOT has already been initiated.
Official title: Benefit of High-flow Nasal Cannula on Persistent Dyspnea in Interstitial Lung Disease: Randomized Multicentric Cross-over Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2024-10-15
Completion Date
2026-10-15
Last Updated
2024-09-27
Healthy Volunteers
No
Conditions
Interventions
long-term oxygen therapy (LTOT)
Usual care with LTOT for 2 weeks
High Flow Nasal Therapy (HFNT)
High Flow Nasal delivered by myAirvo3 (4 hours minimum and during th 3-minute chair rise test, 30L/min, 34°C, identical O2 flow rate as LTOT) for 2 weeks